trospium chloride er- trospium chloride capsule, extended release
bryant ranch prepack - trospium chloride (unii: 1e6682427e) (trospium - unii:t4y8ork057) - trospium chloride extended-release capsules are a muscarinic antagonist indicated for the treatment of overactive bladder (oab) with symptoms of urge urinary incontinence, urgency, and urinary frequency. trospium chloride extended-release capsules are contraindicated in patients with: teratogenic effects pregnancy category c: there are no adequate and well-controlled studies of trospium chloride extended-release capsules in pregnant women. trospium chloride extended-release capsules should be used during pregnancy only if the potential benefit to the patient outweighs the risk to the patient and fetus. women who become pregnant during trospium chloride extended-release capsules treatment are encouraged to contact their physician. trospium chloride was not teratogenic at statistically significant levels in rats or rabbits administered doses up to 200 mg/kg/day. this corresponds to systemic exposures up to approximately 16 and 32 times, respectively (based on auc), the clinical exposure at the maximum recommen
trospium chloride tablet, film coated
bryant ranch prepack - trospium chloride (unii: 1e6682427e) (trospium - unii:t4y8ork057) - trospium chloride tablets are a muscarinic antagonist indicated for the treatment of overactive bladder (oab) with symptoms of urge urinary incontinence, urgency, and urinary frequency. trospium chloride tablets are contraindicated in patients with: teratogenic effects pregnancy category c: there are no adequate and well-controlled studies of trospium chloride tablets in pregnant women. trospium chloride tablets should be used during pregnancy only if the potential benefit to the patient outweighs the risk to the patient and fetus. women who become pregnant during trospium chloride tablets treatment are encouraged to contact their physician. risk summary based on animal data, trospium chloride is predicted to have a low probability of increased risk of adverse developmental outcomes, above background risk. adverse developmental findings were not observed to correlate with dose in rats or in rabbits. no increased risk above background was observed in rats and rabbits treated at an exposure approximately equiv
trospium chloride 20 milligram film coated tablet
auden mckenzie (pharma division) ltd - trospium chloride - film coated tablet - 20 milligram - drugs for urinary frequency and incontinence
trospium chloride
teva b.v. - trospium chloride - film coated tablet - 20 milligram - trospium
accel-trospium tablet
accel pharma inc - trospium chloride - tablet - 20mg - trospium chloride 20mg - antimuscarinics
spasmex 30
tec-o-pharm-libra ltd - trospium chloride - film coated tablets - trospium chloride 30 mg - trospium and analgesics - trospium and analgesics - for the treatment of vegetative bladder dysfunction accompanied by urgency and/or frequency and/or urinary incontinence.
spasmex 15
tec-o-pharm-libra ltd - trospium chloride - film coated tablets - trospium chloride 15 mg - trospium - trospium - for the treatment of vegetative bladder dysfunction accompanied by urgency and/or frequency and/or urinary incontinence.
trospium 20 milligram film coated tablet
glenmark pharmaceuticals europe limited - trospium chloride - film coated tablet - 20 milligram - drugs for urinary frequency and incontinence
mar-trospium tablet
marcan pharmaceuticals inc - trospium chloride - tablet - 20mg - trospium chloride 20mg - antimuscarinics
trospium chloride 20mg/5ml oral solution
special order - trospium chloride - oral solution - 4mg/1ml